Preliminary research show conolidine may perhaps inhibit certain ion channels, lowering neuronal excitability and limiting discomfort signals. This mechanism is particularly appropriate in neuropathic suffering, where irregular signaling results in persistent pain. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR) pathways i